@article{3062858,
    title = "Fluostatins C-E, novel members of the fluostatin family produced by Streptomyces strain acta 1383",
    author = "Baur, S. and Niehaus, J. and Karagouni, A.D. and Katsifas, E.A. and Chalkou, K. and Meintanis, C. and Jones, A.L. and Goodfellow, M. and Ward, A.C. and Beil, W. and Schneider, K. and Süssmuth, R.D. and Fiedler, H.-P.",
    journal = "The Journal of Antibiotics",
    year = "2006",
    volume = "59",
    number = "5",
    pages = "293-297",
    doi = "10.1038/ja.2006.41",
    keywords = "fluorenone derivative;  fluostatin c;  fluostatin d;  fluostatin e;  unclassified drug, article;  chromatophore;  controlled study;  drug activity;  drug isolation;  drug screening;  drug structure;  fermentation;  high performance liquid chromatography;  human;  human cell;  nonhuman;  priority journal;  Streptomyces;  Streptomyces lavendulae;  taxonomy;  tumor cell line, Antineoplastic Agents;  Cell Line, Tumor;  Fluorenes;  Humans;  Molecular Structure;  Spectrometry, Mass, Electrospray Ionization;  Spectrophotometry, Ultraviolet;  Streptomyces, Streptomyces;  Streptomyces lavendulae",
    abstract = "Three new members of the fluostatin family, fluostatins C-E, were discovered in a culture filtrate extract of strain Acta 1383 during an HPLC screening program. The producing strain belongs to the genus Streptomyces and is closely related to type strains classified in the Streptomyces lavendulae 16S rRNA subclade. Fluostatins are named by their characteristic fluorenone chromophore. Fluostatin C shows moderate activity against selected human tumor cell lines. © Japan Antibiotics Research Association."
}